Prognostic significance of tumor mitotic rate in T2 melanoma staged with sentinel lymphadenectomy

E-ISSN： 1096-9098|111|6|711-715

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.6, 2015-05, pp. : 711-715

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Triple‐marker PCR assay of sentinel lymph node as a prognostic factor in melanoma

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 5, 2015-05 ,pp. : 912-918

John Wiley & Sons Inc

Access to resources Recommend Favorite

Multicenter Selective Lymphadenectomy Trial‐I confirms the central role of sentinel node biopsy in contemporary melanoma management

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 571-573

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is mitotic rate still useful in the management of patients with thin melanoma?

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 31, Iss. 12, 2017-12 ,pp. : 2025-2029

John Wiley & Sons Inc

Access to resources Recommend Favorite

Sentinel Lymphadenectomy – Ready for Clinical Routine?

Oncology Research and Treatment, Vol. 23, Iss. 5, 2000-11 ,pp. : 408-409

Karger

Access to resources Recommend Favorite

No survival benefit for patients with melanoma undergoing sentinel lymph node biopsy: critical appraisal of the Multicenter Selective Lymphadenectomy Trial‐I final report

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 3, 2015-03 ,pp. : 566-571

John Wiley & Sons Inc

Access to resources Recommend Favorite